Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...

Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes.

GLP-1 agonists may help reduce acetazolamide dosage in patients with idiopathic intracranial hypertension without changing clinical outcome.

Eli Lilly joins up with Camurus to make long-acting versions of the pharma's obesity and diabetes drugs, joining the industry ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

IN the run up to her 30th birthday, Paige Osprey wanted to look her best – and avoid putting herself at risk of heart disease.  But weighing 13st 8lb, wearing a size 16, and having ...

Research at Harvard—from medicine to technology to education and business—touches countless lives, moving us closer to ...